Atara Bio Announces Proposed Offering of Common Stock
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/27/2026
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Stock action shows confidence in central banks: BofA’s Hartnett
- Oil prices slide about 2% as US, Iran explore path out of war
- Why stocks held up despite rising yields and $100 oil? These 2 words explain it
- Barclays asks if equity markets are nearing the boiling point
- White House blocks CNN from Air Force One trip, Washington Post reports
- Merck and Daiichi Sankyo withdraw lung cancer drug application
- Exclusive-SK Hynix's Solidigm weighs IPO that could value the unit at up to $150 billion, sources say
- Fox Factory sells Marucci Sports for $225M, cuts debt
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
ATARA Biotherapeutics (ATRA) Boosts Common Stock Shelf Size to $150M
July 9, 2015 10:07 AM EDTATARA Biotherapeutics (Nasdaq: ATRA) filed an amended registration with the U.S. SEC to sell up to $150 million of its Common Stock. The amount is up from a previously registered amount of $125 million.
... MoreAtara Biotherapeutics (ATRA) Announces $125M Common Stock Offering
July 7, 2015 4:06 PM EDTAtara Biotherapeutics (NASDAQ: ATRA) has commenced an underwritten public offering of shares of its common stock and expects to raise gross proceeds of approximately $125.0 million. In addition, Atara Bio expects to grant the underwriters a 30-day option to purchase up to an... More
